Factors predictive of the development of Levodopa-induced dyskinesia and wearing-off in Parkinson's disease-Reference-Cited by-同舟云学术

Factors predictive of the development of Levodopa-induced dyskinesia and wearing-off in Parkinson's disease

Published:2013-04-29 Issue:8 Volume:28 Page:1064-1071
ISSN:0885-3185
Container-title:Movement Disorders
language:en
Short-container-title:Mov Disord.

Author:

Warren Olanow C.¹²,Kieburtz Karl³,Rascol Olivier⁴,Poewe Werner⁵,Schapira Anthony H.⁶,Emre Murat⁷,Nissinen Helena⁸,Leinonen Mika⁹,Stocchi Fabrizio²,

Affiliation:

1. Department of Neurology and Neuroscience; Mount Sinai School of Medicine; New York NY USA

2. Institute for Research; Scientific Institute for Care and Treatment; San Raffaele Rome Italy

3. Center for Human Experimental Therapeutics; University of Rochester; New York USA

4. National Institute for Health and Medical Research Unit 455; Clinical Investigation Center; Departments of Clinical Pharmacology and Neurosciences, and Faculty of Medicine; Toulouse France

5. Department of Neurology; Innsbruck Medical University; Innsbruck Austria

6. University Department of Clinical Neurosciences; Institute of Neurology; University College London, National Hospital for Neurology, and Neurosurgery and Royal Free Hospital; London United Kingdom

7. Department of Neurology; Istanbul University; Instanbul Turkey

8. Orion Pharma; Espoo Finland

9. 4Pharma AB; Stockholm Sweden

Publisher

Wiley

Subject

Clinical Neurology,Neurology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/mds.25364/fullpdf

Reference20 articles.

1. Frequency of levodopa-related dyskinesias and motor fluctuations as estimated from the cumulative literature;Ahlskog;Mov Disord,2001

2. Continuous dopamine-receptor treatment of Parkinson's disease: scientific rationale and clinical implications;Olanow;Lancet Neurol,2006